vimarsana.com

Page 9 - ஒன்றுபட்டது கிஂக்டம் போட்டி சந்தைகள் அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Australian And UK Regulator Approval Not Needed For

UK TOP NEWS SUMMARY: UK s Johnson Says No Deal A

UK TOP NEWS SUMMARY: UK s Johnson Says No Deal A Strong Possibility Fri, 11th Dec 2020 11:17 (Alliance News) - The following is a summary of top news stories Friday. COMPANIES GlaxoSmithKline and Sanofi said their Covid-19 vaccine has been delayed to the end of 2021 after interim study result found an insufficient response in older patients. The phase 1/2 study s interim results showed an immune response that was comparable to patients who had recovered from Covid-19 in adults aged 18 to 49, but a low immune response in older adults. The two firms plan to begin a phase 2b study in February 2021 with an improved antigen formulation, which will include a proposed comparison with an already authorised Covid-19 vaccine. With positive data, a global phase 3 study could begin in the second 2021 quarter, and positive results from that would lead to regulatory submissions in the second half of 2021. Overall, this means the vaccine potential availability has moved to the fourth 2021 qua

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.